Cognitive deficits, including memory deficiencies, are currently deemed one of key symptoms of psychopathologic mental disorders or epilepsy. The impairment of neurocognitive processes could be due to the administered therapy, in particular combined therapy or therapy using antiepileptics of older type. Gabapentin (GBP) is one of new antiepileptics with normothymic properties. It is known that epileptic patients run a significant risk of developing depression and mood changes. Smoking may also have a negative effect on memory processes and efficacy of administered drugs. Note that smoking in pregnant women also leads to neurobehavioral changes in their children. The objective of our research was to evaluate the effect of GBP on memory functions and antidepressant effect in rats not exposed and exposed to tobacco smoke in fetal life. We were also intent on finding whether GBP has an anticonvulsant effect in contact and without contact with tobacco smoke, and whether it affects motor coordination in animals if administered in the dose of 25 mg/kg. Spatial memory of the animals was assessed in the Morris test and the antidepressant effect in the Porsolt test. The ED50 value was determined in the Swinyard maximum electric shock test, and the effect on motor coordination was assessed in the chimney test. GBP administered in the dose of 25 mg/kg intraperitoneal (i.p.) significantly reduced the immobility time on days 1 and 7 of the test in animals exposed to tobacco smoke, and on days 7 and 14 of the test in rats not exposed to tobacco smoke. Upon single and multiple administration of GBP to animals not exposed to tobacco smoke, the spatial memory improved, whereas in animals exposed to tobacco smoke in fetal life tolerance for procognitive effect was observed on day 21 of the test. It has been found that in rats not exposed to tobacco smoke, ED50 of GBP was 28.73 mg/kg, whereas in animals exposed to tobacco smoke in fetal life, ED50 was 46.2 mg/kg. Upon 14 and 21 days of drug administration, motor coordination was impaired in both GBP receiving animal groups. In conclusion, GBP beside its anticonvulsant efficacy also improves memory processes and has antidepressant effect. We also proved that GBP may reverse cognitive deficits concerning working memory induced by prenatal exposure to tobacco smoke and may have antidepressant effect in rats exposed to tobacco smoke.
1 Aldenkamp AP Dodson WE , (eds). Epilepsy and education; cognitive factors in learning behavior. Epilepsia1990; 31: 9–20.
2.
2 Dodson WE Pellock JM . Pediatric epilepsy: diagnosis and treatment.New York: Demos Publications; 1993.
3.
3 Hirsch E Schmitz B Carreno M . Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol Scand2003; 108: 23–32.
4.
4 Aldenkamp AP Krom DM Reijs R . Newer antiepileptic drugs and cognitive issues. Epilepsia2003; 44: 21–29.
5.
5 Meador KJ Gilliam FG Kanner AM . Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav2001; 2: 1–17.
6.
6 Meador KJ Loring DW Moore EE Thompson WO Nichols ME Oberzan RE . Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology1995; 45: 1494–1499.
7.
7 Loescher W Schmidt D . New horizons in the development of antiepileptic drugs. Epilepsy Res2002; 50: 3–16.
8.
8 Privitera M Fincham R Penry J Reife R Kramer L Pledger G . Topiramate placebocontrolled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages. Topiramate YE study group. Neurology1996; 46: 1678–1683.
9.
9 Brunbech L Sabers A . Effect of antiepileptic drugs on cognitive function in individuals with epilepsy. A comparative review of newer versus older agents. Drugs2002; 62: 593–604.
10.
10 Trimble MR . Quality of life and cognitive function. In: MR Trimble WE Dodson , (eds), Epilepsy and quality of life.New York: Raven Press Ltd; 1994.
11.
11 Aldenkamp AP Hendriks M . Managing cognitive and behavioural consequences of epilepsy. In: GA Baker A Jacoby , (eds), Quality of life in epilepsy.Amsterdam: Harwood Academic Publishers; 2000.
12.
12 Mendez MF Cummings JL Benson DF . Depression in epilepsy. Significance and phenomenology. Arch Neurol1986; 43: 766–770.
13.
13 Robertson M Trimble M Townsend H . Phenomenology of depression in epilepsy. Epilepsia1987; 28: 364–372.
14.
14 Matthews W Barabas G . Suicide and epilepsy: a review of the literature. Psychosomatics1981; 22: 515–524.
15.
15 Betts T . Depression, anxiety, and epilepsy. In: E Reynolds M Trimble , (eds), Eplepsy and psychiatry.New York: Churchill Livingstone; 1981. p. 60–66.
16.
16 Kanner AM Balabanov A . Depression and epilepsy. How closely related are they. Neurology2002; 58: 27–39.
17.
17 Rosenstein DL Nelson JC Jacobs SC . Seizures associated with antidepressants: a review. J Clin Psychiatry1993; 54: 289–299.
18.
18 Skowron DM Stimel GL . Antidepressants and the risk of seizures. Pharmacotherapy1992; 12: 18–22.
19.
19 Dimond KR Pande AC Lamoreus L Pierce MW . Effect of gabapentin (Neurotin) on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry1996; 20: 407–417.
20.
20 Harden CL Pick LH . Alterations in mood and anxiety in epilepsy patients treated with gabapentin. Epilepsia1996; 37: 137 (Abstract).
21.
21 Mortimore CM Trimble M Emmers E . Effect of gabapentin on cognition and quality of life in patients with epilepsy. Seizure1998; 7: 359–364.
22.
22 Dodrill CB Arnett JL Hayes AG Garofalo EA Greeley CA Greiner MJ . Cognitive abilities and adjustment with gabapentin: results of a multisite study. Epilepsy Res1999; 35: 109–121.
23.
23 Nowakowska E Kus K Florek E Czubak A Jodynie-Liebert J . The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine. Hum Exp Toxicol2006; 25: 199–209.
24.
24 Fried PA . Clinical implications of smoking: Determining long-term teratogenicity. In: IS Zagon TA Slotkin , (eds), Maternal Substance abuse and the developing nervouse system.New York: Academic Press; 1992. p. 77–96.
25.
25 Dunn HG McBurney AK . Cigarette smoking and the fetus and child. Pediatrics1977; 60: 772–773.
26.
26 Naeye RL Peters EC . Mental development of children whose mothers smoked during pregnancy. J Am Coll Obstetricians Gynecologists1984; 64: 601–607.
27.
27 Rantakallio P . A follow-up study up to the age of 14 of children whose mothers smoked during pregnancy. Acta Paediatr Scand1983; 72: 747–753.
28.
28 Jacobson SW Fein GG Jacobson JJ Schwartz PM Dowler JK . Neonatal correlates of prenatal exposure to smoking, caffeine and alcohol. Infant Behav Dev1984; 7: 253–265.
29.
29 Landesman-Dwyer S Emanuel I . Smoking during pregnancy. Teratology1979; 19: 119–126.
30.
30 Picone AP Allen LH Olsen PN Ferris ME . Pregnancy out in North American women. II. Effects of diet, cigarette smoking, stress and weight gain on placentas and on neonatal physical and behavioral characteristics. Am J Clin Nutr1982; 36: 1214–1224.
31.
31 Streissguth AP Martin DC Barr HM Sandman BM Kirchner GL Darby BL . Intrauterine alcohol and nicotine exposure: attention and reaction time in 4-year-old children. Dev Psychol1984; 20: 533–541.
32.
32 Butler NR Goldstein H . Smoking in pregnancy and subsequent child development. Br Med J1973; 4: 573–575.
33.
33 DiFranza JR Lew RA . Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. J Fam Pract1995; 40: 385–394.
34.
34 Milberger S Biederman J Faraone SV Jones J . Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. J Clin Child Psychol1998; 27: 352–358.
35.
35 Niaura R Bock B Lloyd EE Brown R Lipsitt LP Buka S . Maternal transmission of nicotine dependence: psychiatric, neurocognitive and prenatal factors. Am J Addict2001; 10: 16–29.
36.
36 Orlebeke JF Knol DL Verhulst FC . Child behavior problems increased by maternal smoking during pregnancy. Arch Environ Health1999; 54: 15–19.
37.
37 Wakschlag LS Lahey BB Loeber R Green SM Gordon RA Leventhal BL . Maternal smoking during pregnancy and the risk of conduct disorder in boys. Arch Gen Psychiatry1997; 54: 670–676.
38.
38 Kristjansson EA Fried PA Watkinson B . Maternal smoking during pregnancy affects children’s vigilance performance. Drug Alcohol Depend1989; 24: 11–19.
39.
39 Denson R Nanson JL McWatters MA . Hyperkinesis and maternal smoking. Can Psychiatr Assoc J1975; 20: 183–187.
40.
40 Ernst M Moolchan ET Robinson ML . Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry2001; 40: 630–641.
41.
41 Lichtensteiger W Ribary U Schlumpf M Odermatt B Widmer HR . Prenatal adverse effects of nicotine on the developing brain. Prog Brain Res1988; 73: 137–157.
42.
42 Olsen J . Cigarette smoking in pregnancy and fetal growth. Does the type of tobacco play a role. Int J Epidemiol1992; 21: 279–284.
43.
43 Slikker WJ Xu Alex Z Levin ED Slotkin TA . Mode of action: Disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction—developmental neurotoxicity of nicotine. Crit Rev Toxicol2005; 35: 703–711.
44.
44 Florek E Marszalek A . An experimental study of the in fluences of tobacco smoke on fertility and reproduction. Hum Exp Toxicol1999; 18: 272–278.
45.
45 Florek E Marszałek A Biczysko W Szymanowski K . The experimental investigations of the toxic influence of tobacco smoke affecting progeny during pregnancy. Hum Exp Toxicol1999; 18: 245–251.
46.
46 Lucki I . The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol1998; 8: 523–532.
47.
47 Porsolt RD Le Pichon M Jalfre M . Depression: a new model sensitive to antidepressant treatments. Nature1977; 266: 730–732.
48.
48 Porsolt RD Anton G Blavet N Jalfre M . Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol1978; 47: 379–391.
49.
49 Borsini F Meli A . Is the forced swimming test a suitable model for revealing antidepressant activity. Psychopharmacology1988; 94: 147–160.
50.
50 Morris R . Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods1984; 11: 47–60.
51.
51 Boissier PJR Tardy J Diverres JC . Une nouvelle methode simple pour Explorer l’action “tranquillisante”: le test de la cheminee. Med Exp1960; 3: 423–425.
52.
52 Swinyard E Brown W Godman L . Comparative assays of antiepileptic drugs, mice and rats. J Pharmacol Exp Ther1952; 106: 319–320.
53.
53 Dougherty JA Rhoney DH . Gabapentin: a unique antiepileptic agent. Neurol Res2001; 23: 821–829.
54.
54 Pande AC Davidson JR Jefferson JW Janney CA Katzelnick DJ Weisler RH . Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol1999; 19: 341–348.
55.
55 Altshuler LL Keck PE McElroy SL Suppes T Brown ES Denicoff K . Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord1999; 1: 61–65.
56.
56 Halczuk I; . Effects of new antiepileptic drugs on cognitive functions. Farmakoterapia w Psychiatrii i Neurologii 2005, 4: 363–379.
57.
57 Meador KJ . Can we treat cognitive deficits in patients with epilepsy. Epilepsy Behav2001; 2: 307–378.
58.
58 Motamedi G Meador K . Epilepsy and cognition. Epilepsy Behav2003; 4: 825–838.
59.
59 Elger EC Helmstaedter C Kurthen M . Chronic epilepsy and cognition. Lancet Neurol2004; 3: 663–672.
60.
60 Ferrier C Thompson JM . Cognitive impairment in bipolar affective disorder: implications for the bipolar diathesis. Br J Psychiatry2002; 180: 293–295.
61.
61 Leach JP Girvan J Paul A Brodie MJ . Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry1997; 62: 372–376.
62.
62 Shannon HE Love PL . Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats. Epilepsy Behav2004; 5: 857–865.
63.
63 Rizwan AN Ali A Dua Y Pal SN Pillai KK . Effects of gabapentin and antidepressant drug combinations on convulsions and memory in mice. Pol J Pharmacol2003; 55: 965–971.
64.
64 Fried PA . Cigarettes and marijuana: Are there measurable long-term neurobehavioral teratogenic effects. Neurotoxicology1989; 10: 577–584.
65.
65 Fogelman KR Manor O . Smoking in pregnancy and development into early adulthood. Br J Med1988; 297: 1233–1236.
66.
66 Hardy JB Mellits ED . Does maternal smoking during pregnancy have a long-term effect on the child. Lancet1972; 7791: 1332–1336.
67.
67 Lefkowitz MM . Smoking during pregnancy: long-term effects on the offspring. Dev Psychol1981; 17: 192–194.
68.
68 Acosta GB Boccia MM Bartni CM . Gabapentin, an antiepileptic drug, improves memory storage in mice. Neurosci Lett2000; 279: 173–176.
69.
69 Cilio MR Bolano AR Liu Z Schmid R Yang Y Stafstrom CE . Anticonvulsant action and long-term effects of gabapentin in the immature brain. Neuropharmacology2001; 40: 139–147.
70.
70 Brioni JD . Role of GABA during the multiple consolidation of memory. Drug Develop Res1993; 28: 3–27.
71.
71 Brioni JD McGaugh JL . Post-training administration of GABAergic antagonists enhances retention of aversively motivated tasks. Psychopharmacology1988; 96: 505–510.
72.
72 Boccia MM Kopf SR Baratti CM . The enhancement of retention performance induced by picrotoxin in mice may be mediated through a release of endogenous vasopressin. Behav Pharmacol1996; 7: 254–260.
73.
73 Saletu B Grunberger J Linzmayer L . Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. Int J Clin Pharmacol1986; 24: 362–373.
74.
74 Dodrill CB Wilensky AJ Ojemann LM . Neuropsychological, mood, and psychosocial effects of gabapentin. Epilepsia1992; 33: 117–118.
75.
75 Schmid G Sala R Bonanno G Ruther M . Neurosteroids may differentially affect the function of two native GABA (A) receptor subtypes in the rat brain. Naunyn Schmiedebergs Arch Pharmacol1998; 357: 401–407.
76.
76 Fassio A Bonanno G Fontana G Usai C Machi M Raiteri M . Role of external and internal calcium on heterocarriermediated transmitter release. J Neurochem1996; 66: 1468–1474.
77.
77 Ramasubbu R . Antidepressant treatment-associated behavioural expression of hypomania: a case series. Prog Neuropsychopharmacol Biol Psychiatry2004; 28: 1201–1207.
78.
78 Southam E Kirkby D Higgens GA Hagan RM . Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytriptamine uptake in rats. Eur J Pharmacol1998; 358: 19–24.
79.
79 McElroy SL Soutullo CA Keck PE Kmetz GF . A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry1997; 9: 99–103.
80.
80 Bowden CL . Pharmacological treatment of bipolar disorder. In: Bipolar Disorders. Chichester, Ed., M Maj, HS Akiskal, JJ Lopez-Ibor, N Sartorious. UK: John Wiley and Sons Ltd; 2002. p. 191–221.
81.
81 Pande AC Crockatt JG Janney CA Werth JL Tsaroucha G . Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Bipolar Disord2000; 2: 249–255.
82.
82 Srivastava SK . Facilitation of behavioural depression by antiepileptic drugs. Indian J Pharmacol2000; 32: 31–33.
83.
83 Post RM Ketter TA Joffe RT Kramlinger KL . Lack of beneficial effects of L-baclofen in affective disorders. Int Clin Psychopharmacol1991; 6: 197–207.
84.
84 Lloyd KG Morselli PL Bartholin G . GABA and affective disorders. Med Biol1987; 65: 159–165.
85.
85 Navarro HA Seidler FJ Schwartz RD Baker FE Dobbins SS Slotkin TA . Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res Bull1989; 23: 187–192.
86.
86 Wonnacott S . Presynaptic nicotinic ACh receptors. Trends Neurosci1997; 20: 92–98.
87.
87 Muneoka K Nakatsu T Fuji J Ogawa T Takigawa M . Prenatal administration of nicotine results in dopaminergic alterations in the neocortex. Neurotoxicol Teratol1999; 21: 603–609.
88.
88 Muneoka K Ogawa T Kamei K Mimura Y Kato H Takigawa M . Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain. Eur J Pharmacol2001; 411: 279–282.
89.
89 Carr LA Walters DE Meyer DC . Postnatal development in the rat following pre- or postnatal exposure to nicotine. Res Commun Subst Abuse1985; 6: 151–164.
90.
90 Benwell MEM Balfour DJK . Effects of nicotine administration on the uptake and biosynthesis of 5-HT in rat brain synaptosomes. Eur J Pharmacol1982; 84: 71–77.
91.
91 Vetulani J Sulser F . Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature1975; 257: 495–496.
92.
92 Ortinski P Meador KJ . Cognitive side effects of antiepileptic drugs. Epilepsy Behav2004; 5: 60–65.
93.
93 Dalby NO Nielsen EB . Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res1997; 28: 63–72.
94.
94 De Sarro G Spagnolo C Gareri P Gallelli L De Sarro A . Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice. Eur J Pharmacol1998; 349: 179–185.
95.
95 Czapiński P Blaszczyk B Czuczwar SJ . Mechanisms of action of antiepileptic drugs. Curr Top Med Chem2005; 5: 1–9.
96.
96 Britos SA Orsingher OA . Prenatal nicotine exposure increased susceptibility to electroconvulsive shock (ECS) in adult rats. Neurotoxicol Teratol1991; 13: 271–273.
97.
97 Taylor CP Gee NS Su TZ Kocsis JD Welty DF Brown JP . A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res1998; 29: 233–249.
98.
98 Taylor CP . Mechanisms of action of gabapentin. Drugs Today1998; 34: 3–11.
99.
99 Luszczki JJ Czuczwar SJ . Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study. Naunyn Schmiedebergs Arch Pharmacol2004; 369: 434–446.
